Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation

N Gaborit, M Steenman, G Lamirault, N Le Meur… - Circulation, 2005 - Am Heart Assoc
N Gaborit, M Steenman, G Lamirault, N Le Meur, S Le Bouter, G Lande, J Léger…
Circulation, 2005Am Heart Assoc
Background—Valvular heart disease (VHD), which often leads to atrial fibrillation (AF), and
AF both cause ion-channel remodeling. We evaluated the ion-channel gene expression
profile of VHD patients, in permanent AF (AF-VHD) or in sinus rhythm (SR-VHD), in
comparison with patients without AF or VHD, respectively. Methods and Results—We used
microarrays containing probes for human ion-channel and Ca2+-regulator genes to quantify
mRNA expression in atrial tissues from 7 SR-VHD patients and 11 AF-VHD patients relative …
Background— Valvular heart disease (VHD), which often leads to atrial fibrillation (AF), and AF both cause ion-channel remodeling. We evaluated the ion-channel gene expression profile of VHD patients, in permanent AF (AF-VHD) or in sinus rhythm (SR-VHD), in comparison with patients without AF or VHD, respectively.
Methods and Results— We used microarrays containing probes for human ion-channel and Ca2+-regulator genes to quantify mRNA expression in atrial tissues from 7 SR-VHD patients and 11 AF-VHD patients relative to 11 control patients in SR without structural heart disease (SR-CAD). From the data set, we selected for detailed analysis 59 transcripts expressed in the human heart. SR-VHD patients differentially expressed 24/59 ion-channel and Ca2+-regulator transcripts. There was significant overlap between VHD groups, with 66% of genes altered in SR-VHD patients being similarly modified in AF-VHD. Statistical differences between the AF- and SR-VHD groups identified the specific molecular portrait of AF, which involved 12 genes that were further confirmed by real-time reverse transcription–polymerase chain reaction. For example, phospholamban, the β-subunit MinK (KCNE1) and MIRP2 (KCNE3), and the 2-pore potassium channel TWIK-1 were upregulated in AF-VHD compared with SR-VHD, whereas the T-type calcium-channel Cav3.1 and the transient-outward potassium channel Kv4.3 were downregulated. Two-way hierarchical clustering separated SR-VHD from AF-VHD patients. AF-related changes in L-type Ca2+-current and inward-rectifier current were confirmed at protein and functional levels. Finally, for 13 selected genes, SR restoration reversed ion-channel remodeling.
Conclusions— VHD extensively remodels cardiac ion-channel and transporter expression, and AF alters ion-channel expression in VHD patients.
Am Heart Assoc